MarketPeel
Insider Trading Intelligence
NB

Noah Berkowitz

ARVN
CHIEF MEDICAL OFFICER · ARVINAS, INC. · CIK 0001369900
FILING MIX · LIFETIME67%/33%
BUYS
8
SELLS
4
TOTAL VALUE
$323.8K
COMPANIES
1
ACTIVE SINCE
Mar 2024
HOLDINGS NOW
191,395
AVG SELL PX
$10.15
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Noah Berkowitz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%-2.33%+0.93%-3.26%-2.68%
14d4+50.00%-1.12%-0.01%+0.49%+4.98%
30d4+25.00%-4.20%-0.17%-4.03%+0.46%
60d4(1 pending)+100.00%-13.42%+6.78%-20.19%-23.98%
90d4(1 pending)+100.00%-20.55%+10.25%-30.80%-26.39%
180d4(3 pending)+100.00%-8.08%+18.16%-26.23%-26.23%
1y4(3 pending)+0.00%+29.34%+18.25%+11.08%+11.08%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARVN · 191,395 shares · as of May 11, 2026
052,235104,469156,704208,93820252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 4 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARVN
ARVINAS, INC.
SALE
Chief Medical Officer
11,108$9.94$110.4K191,395May 11, 2026May 13, 2026View →
ARVN
ARVINAS, INC.
SALE
Chief Medical Officer
6,435$11.10$71.4K202,503Mar 18, 2026Mar 19, 2026View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
67,00067,000Feb 26, 2026Mar 2, 2026View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
45,000208,938Feb 26, 2026Mar 2, 2026View →
ARVN
ARVINAS, INC.
SALE
Chief Medical Officer
5,685$11.89$67.6K163,938Feb 13, 2026Feb 18, 2026View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
91,00091,000May 9, 2025May 13, 2025View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
59,600169,623May 9, 2025May 13, 2025View →
ARVN
ARVINAS, INC.
SALE
Chief Medical Officer
8,658$8.59$74.4K110,023Mar 18, 2025Mar 18, 2025View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
55,229118,681Feb 13, 2025Feb 18, 2025View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
84,33084,330Feb 13, 2025Feb 18, 2025View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
93,87993,879Mar 18, 2024Mar 21, 2024View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
63,45263,452Mar 18, 2024Mar 21, 2024View →
Other insiders · ARVN
Loading peer insiders…
About this filer
CIK 0001369900
ROLE
Chief Medical Officer
PRIMARY
ARVN
COMPANIES
1
ACTIVE SINCE
Mar 2024
MARKETPEEL · /INSIDER/0001369900DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback